Abstract
Because of the importance of cholesterol metabolism in the physiopathogenesis of dementia, and knowing the function of ATP-binding cassette A1 transporter (ABCA1) as a cholesterol flow pump at the cellular and cerebral level, it has been noted that the ABCA1 gene may be a good candidate for disease study. In order to evaluate the relationship between ABCA1 genetic variants and the risk of Alzheimer’s disease and other dementia in Mexican individuals, we examined three ABCA1 polymorphisms located in the exonic region (rs2230808, rs2066718, rs2230806) and two in the promoter region (rs1800977, rs2422493) in a group of 557 normal controls and 221 cases of dementia. It was possible to distinguish one protective haplotype: CCCCGC (OR = 0,502, 95% CI = 0,370-0,681, p < 0.001), and one risk haplotype TCCCAT (OR = 2208, 95% CI = 1609-3031, p < 0.000) for the development of dementia. The results suggest that ABCA1 plays an important role in the pathophysiological mechanisms for the development of dementia.
Similar content being viewed by others
References
Acuna-Alonzo V, Flores-Dorantes T, Kruit JK, Villarreal-Molina T, Arellano-Campos O, Hunemeier T et al (2010) A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans. Hum Mol Genet 19:2877–2885
Alzheimer's Association (2013) Alzheimer’s disease facts and figures. Alzheimers Dement 9:208–245
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2:263–265
Beffert, U., Aumont, N., Dea, D., Lussier-Cacan, S., Davignon, J. and Poirier, J. (1999). Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures. Brain Res. Mol. Brain Res 68, 181–185
Bodzioch M, Orsó E, Klucken J, Langmann T, Böttcher A, Diederich W, Drobnik W, Barlage S, Büchler C, Porsch-Özcürümez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347–351
Chu LW, Li Y, Li Z, Tang AY, Cheung BM, Leung RY, Yik PY, Jin DY, Song YQ (2007) A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer’s disease in Chinese.AmJ Med Genet B Neuropsychiatr Genet 144B:1007–1013
Demeester N, Castro G, Desrumaux C, De Geitere C, Fruchart J, Santens P, Mulleners E, Engelborghs S, De Deyn P, Vandekerckhove J (2000) Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin: cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J Lipid Res 41:963–974
DSM (2001) Diagnostic and statistical manual of mental disorders, fourth edition, text revision: DSM-IV-TR quick reference to the diagnostic criteria from DSM-IV-TR. JAMA. 6:811–812
Fehér Á, Giricz Z, Juhász A, Pákáski M, Janka Z, Kálmán J. (2018) ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease. Neurosci Lett. Jan 18;664:79-83
González-Chávez A, Vidales JA, Camacho J, Alexanderson-Rosas EG, Alcántara-Vázquez A (1999) Síndrome de deterioro intelectual: nuevos conceptos para el diagnóstico y tratamiento. Rev Med Hosp Gen Mex 62:38–47
Guerreiro R, Hardy J (2014) Genetics of Alzheimer’s disease. Neurotherapeutics;; Springer 4:737–737
Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY (2004) Tansley GH, Cohn JS, Hayden MR, Wellington CL. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem 279:41197–41207
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572
Juarez-Cedillo T, Sanchez-Arenas R, Sanchez-Garcia S, Garcia-Peña C, Hsiung GY, Sepehry AA, Beattie BL, Jacova C (2012) Prevalence of mild cognitiveimpairment and its subtypes in the Mexican population. Dement GeriatrCogn Disord 34:271–281
Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA (2004) Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 23:358–367
Kazi D, Farmer JA. (2005). Raising high-density lipoprotein cholesterol; innovative strategies against an old adversary. Curr Atheroscler rep.7:88-94
Khorram Khorshid HR, Gozalpour E, Kamali K, Ohadi M, Karimloo M, Shahhosseiny MH (2011) The association between sporadic Alzheimer’s disease and the human ABCA1 and APOE gene polymorphisms in Iranian population. Iran Red Crescent Med J 13:256–262
Kuhnke, D. G. Jedlitschky, M. Grube, M. Krohn, M. Jucker, I. Mosyagin, I. et al., (2007) MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides−implications for the mechanisms of Abeta clearance at the blood-brain barrier, Brain Pathol 17;347–353
Lahiri DK, Nurnberger JI Jr. (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res.19(19):5444
Lewis CM (2002) Genetic association studies: design, analysis and interpretation. Brief Bioinform 3:146–153
Li Y, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Schrodi S, Leong D, Lau K, Catanese J, Sninsky J, Nowotny P, Holmans P, Hardy J, Powell J, Lovestone S, Thal L, Owen M, Williams J, Goate A, Grupe A (2004) Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett 366:268–271
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology.34:939-44
Minagawa H, Gong JS, Jung CG, Watanabe A, Lund-Katz S, Phillips MC et al (2009) Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture. J Neurosci Res 11:2498–2508
Morgan K, Carrasquillo M (2007) Editors. Genetic variants in Alzheimer disease; (2013). Nueva York: springer pp 231–50. Barrow C., small D.; A-beta peptide and Alzheimer’s disease. Springer, London
Morgan, K., & Carrasquillo, M. M. (2013). Genetic variants in Alzheimer's disease. Springer New York. https://doi.org/10.1007/978-1-4614-7309-1
Oram JF, Heinecke JW (2005) ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85:1343–1372
Penke B, Paragi G, Gera J, Berkecz R, Kovacs Z, Crul T, Vigh L (2018) The role of lipids and membranes in the pathogenesis of Alzheimer's disease: a comprehensive view. Curr Alzheimer Res 15:1191–1212
Prince M, Albanese E, Guerchet M, Prina M (2014) World Alzheimer report (2014): dementia and risk reduction. An analysis of protective and modifiable risk factors. Alzheimer Disease International, London
Reyes de Beaman S, Peter E, Beaman PE, Garcia-Peña C, Villa MA, Heres J, Córdova A, Jagger C (2004) Validation of a modified version of the mini-mental state examination (MMSE) in Spanish. Aging Neuropsychol Cognition 1:1–11
Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J et al (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci Off J Soc Neurosci 45:11445–11453
Robles A, Del Ser T, Alom J, Peña-Casanova, (2002) Grupo Asesor del Grupo de Neurología de la Conducta y Demencias de la Sociedad Española de Neurología. Propuesta de criterios para el diagnóstico clínico del deterioro cognitivo ligero, la demencia y la enfermedad de Alzheimer. Neurologia 17:17–32
Rodriguez-Rodriguez E, Mateo I, Llorca J, Sanchez-Quintana C, Infante J, Garcia-Gorostiaga I, Sanchez-Juan P, Berciano J, Combarros O (2007) Association of genetic variants of ABCA1 with Alzheimer’s disease risk. Am J Med Genet Part B Neuropsychiatr Genet Off Publ Int Soc Psychiatr Genet 144B(7):964–968
Rodriguez-Rodriguez E, Mateo I, Infante J, Llorca J, Garcia-Gorostiaga I, Vazquez-Higuera JL, Sanchez-Juan P, Berciano J, Combarros O (2009) Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer’s disease risk. Brain Res 1280:166–171
Rodriguez-Rodriguez E, Vazquez-Higuera JL, Sanchez-Juan P, Mateo I, Pozueta A, Martinez-Garcia A, Frank A, Valdivieso F, Berciano J, Bullido MJ, Combarros O (2010) Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer’s disease risk. J Alzheimer’s Dis JAD 21(2):619–625
Romano PS, Roos LL, Jollis JG (1993) Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 46:1075–1079
Shibata N, Kawarai T, Lee JH, Lee HS, Shibata E, Sato C, Liang Y, Duara R, Mayeux RP, St George-Hyslop PH, Rogaeva E (2006) Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer’s disease. Neurosci Lett 391:142–146
Sparks DL, Hunsaker JC, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer’s disease. Neurobiol Aging 11:601–607
StataCorp (2013) Stata statistical software: release 13. StataCorp LP, College Station, TX
Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93–112
Sun YM, Li HL, Guo QH, Wu P, Hong Z, Lu CZ, Wu ZY (2012) The polymorphism of the ATP-binding cassette transporter 1 gene modulates Alzheimer disease risk in Chinese Han ethnic population. Am J Geriatr Psychiatry 20:603–611
Sundar PD, Feingold E, Minster RL, DeKosky ST, Kamboh MI (2007) Gender specific association of ATPbinding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol Aging 28:856–862
Vargas-Alarcón G, Juárez-Cedillo E, Martínez-Rodríguez N, Fragoso JM, García-Hernández N, Juárez-Cedillo T. (2016). Association of interleukin-10 polymorphisms with risk factors of Alzheimer's disease and other dementias (SADEM study). Immunol Lett. Sep;177:47-52
Villarreal-Molina MT, Aguilar-Salinas CA, Rodriguez-Cruz M, Riano D, Villalobos-Comparan M, Coral-Vazquez R, Menjivar M, Yescas-Gomez P, Konigsoerg-Fainstein M, Romero-Hidalgo S, Tusie-Luna MT, Canizales-Quinteros S, the Metabolic Study Group (2007) The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities. Diabetes. 56:1881–1887
Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocytesecreted apoE. J Biol Chem 279:40987–40993
Wavrant-De VF, Compton D, Womick M, Arepalli S, Adighibe O, Li L, Perez-Tur J, Hardy J (2007) ABCA1 polymorphisms and Alzheimer's disease. Neurosci Lett 416:180–183
Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161–169
Acknowledgements
This project was supported by grants from SSA/IMSS/ISSSTE-CONACYT (México) SALUD- 233065. Authors thank Susan Drier Jonas for her assistance with the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to report.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Teresa, JC., Fernado, C., Nancy, MR. et al. Association of genetic variants of ABCA1 with susceptibility to dementia: (SADEM study). Metab Brain Dis 35, 915–922 (2020). https://doi.org/10.1007/s11011-020-00577-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-020-00577-4